Skip to content
Clinical Trials – home
Medical University Of Gdansk
Sponsor

Medical University Of Gdansk

Poland Ul. Marii Sklodowskiej-Curie 3a, 80-210 Gdansk, Poland

About the sponsor

Medical University Of Gdansk supports clinical research in acute ischemic stroke, acute coronary syndrome, non-valvular atrial fibrillation, and heart failure with preserved ejection fraction. Its portfolio also includes Takotsubo syndrome and related cardiomyopathy conditions.

  • Thrombolysis and thrombectomy in stroke
  • Antithrombotic treatment in atrial fibrillation and coronary disease
  • Heart failure, cardiomyopathy, and Takotsubo syndrome

Research activity extends to cardiovascular risk management, recovery after vascular events, and functional outcomes in patients with complex cardiac and neurological disease.

About Specializations

Medical University Of Gdansk runs clinical trials in conditions such as Ischaemic stroke, Heart failure with preserved ejection fraction, Systemic mastocytosis, Hodgkin's disease, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

15 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Medical University Of Gdansk
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Medical University Of Gdansk
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Medical University Of Gdansk

Hepatoblastoma

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nintedanib
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Rituximab
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Valsartan
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ticagrelor
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Medical University Of Gdansk
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Metoprolol Tartrate
  • Sponsor:Medical University Of Gdansk

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).